NGM NGM Biopharmaceuticals, Inc.

Develops transformational biologics for the treatment of cardio-metabolic conditions

$20.45  +0.08 (0.39%)
As of 06/25/2021 09:39:24 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/16/2013
Outstanding shares:  77,018,206
Average volume:  573,556
Market cap:   $1,551,146,669
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    62921N105
ISIN:        US62921N1054
Sedol:      BJ1FD63
Valuation   (See tab for details)
PE ratio:   -14.14
PB ratio:   3.92
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy